Related by context. All words. (Click for frequent words.) 73 Investigational Treatment 73 Relapsed Refractory 73 Severe Sepsis 72 Complicated Skin 72 myelodysplastic myeloproliferative diseases 72 Primary Hypercholesterolemia 72 Mg Uk 72 Patients Treated With 72 Newly Diagnosed Multiple Myeloma 72 Improves Outcomes 72 Antitumor Activity 72 Renal Impairment 72 recurrent glioblastoma multiforme 71 Patients Receiving 71 deep venous thromboses 71 non splenectomized 71 mild renal insufficiency 71 alfa 2a 71 Oral Fingolimod 71 Slow Progression 71 Relapsing Multiple Sclerosis 71 SPRYCEL ® 71 Adjuvant Treatment 71 Juvenile Idiopathic Arthritis 71 moderate hepatic impairment 71 Meets Primary Endpoint 71 R lenalidomide 71 Abrupt discontinuation 71 bone marrow reticulin deposition 71 Mg Usa 71 Atomoxetine 71 INSPIRE Trial Phase III 70 See CLINICAL PHARMACOLOGY 70 Naive Patients 70 Hormone Refractory Prostate Cancer 70 Advanced Melanoma 70 metastatic malignant 70 Node Positive 70 myocardial infarction ventricular fibrillation 70 hyperphenylalaninemia HPA due 70 Reduces Mortality 70 Adjunctive Therapy 70 Dementia Related Psychosis 70 Pediatric Patients 70 chronic eosinophilic leukemia 70 Phase 2b Clinical Trial 70 relapsed MM 70 Relapsing Remitting Multiple Sclerosis 70 Myelodysplastic Syndrome MDS 70 Secondary Hyperparathyroidism 70 Generalized Anxiety Disorder GAD 70 Metastatic Prostate Cancer 70 Ischemic Stroke 70 quetiapine Seroquel 70 Previously Treated 70 venlafaxine Effexor 70 Bipolar Mania 70 R Saizen R 70 Thromboembolism 70 Chronic Insomnia 70 ACTEMRA TM 69 receiving XGEVA 69 ® lenalidomide 69 Non Alcoholic Steatohepatitis 69 AA Amyloidosis 69 Liver Failure 69 PEGINTRON TM 69 Slows Progression 69 Renal Cell Carcinoma 69 chronic immune thrombocytopenic 69 hyperplasia BPH 69 Acute Exacerbations 69 relapsed ALL 69 primary immunodeficiency PI 69 ACE Inhibitors 69 HeFH 69 Demonstrates Positive 69 Refractory Hodgkin Lymphoma 69 ergot derivatives 69 leukemia AML 69 LHRH receptor positive 69 Achieves Primary Endpoint 69 CIMZIA TM certolizumab pegol 69 J Am Acad 69 Decompensated Heart Failure 69 Nilotinib 69 acute peptic ulcer 69 Peptic Ulcer 69 Patients Undergoing 69 Prolongs Survival 69 Bronchopulmonary Dysplasia 69 Adjunctive 69 retinal vein occlusion induced 69 Sipuleucel T 69 Combination Treatment 69 VICTOR E3 69 chronic thromboembolic pulmonary 69 Geodon ziprasidone 69 Philadelphia Chromosome Positive 69 Pegloticase 69 Paroxysmal Nocturnal Hemoglobinuria PNH 69 oral dual endothelin 69 #-# Full Text 69 Thiazolidinediones 69 Chronic Constipation 69 Zorbtive TM 69 oral antidiabetic medication 69 Demonstrates Sustained 69 Appears Safe 69 dual endothelin receptor antagonist 69 Relapsed Multiple Myeloma 69 Treatment Naive Patients 69 Mylan Receives Approval 69 Aflibercept 69 Degarelix 69 Telithromycin 69 PLX STROKE targeting 69 Nebulized 69 cisplatin gemcitabine 68 Amgen Neulasta R 68 Unstable Angina 68 HIV HCV coinfected 68 Transdermal Patch 68 Cognitive Impairment 68 eosinophilic asthma 68 Chronic Myeloid Leukemia 68 Nonalcoholic Fatty Liver Disease 68 #:#-# [031] 68 Recurrent Glioblastoma 68 Subgroup Analysis 68 Study Evaluating 68 refractory chronic lymphocytic 68 FDA APPROVES 68 hypereosinophilic syndrome 68 Peginterferon Alfa 2a 68 Completes Patient Enrollment 68 TNF Blockers 68 PYY #-# 68 Adjuvant Chemotherapy 68 Atypical Hemolytic Uremic Syndrome 68 Bisphosphonate 68 Sprycel dasatinib 68 AVAPRO 68 Successfully Treats 68 Controlled Trial 68 PEGylated anti 68 receiving prophylactic anticoagulation 68 Septic Shock 68 Comorbidities 68 Bosutinib 68 MAGE A3 ASCI 68 systemic invasive fungal 68 finasteride Proscar 68 sertraline Zoloft 68 Drug Prevents 68 homozygous familial hypercholesterolemia 68 Resistant Hypertension 68 Pooled Analysis 68 Chronic Heart Failure 68 ORENCIA ® 68 Combination REOLYSIN R 68 Premature Infants 68 Heart Failure Patients 68 Paxil paroxetine 68 metastatic colorectal carcinoma 68 included exfoliative dermatitis 68 de novo kidney transplant 68 adalimumab Humira 68 AVONEX ® 68 primary hypercholesterolemia 68 Relapsed Refractory Multiple Myeloma 68 Tyrosine Kinase Inhibitor 68 purpura ITP 68 administered concomitantly 68 Leukemias 68 Prophylactic Treatment 68 acarbose 68 Eltrombopag 68 EFFEXOR XR 68 Rotavirus Vaccine 68 interferon beta 1a infertility 68 decompensated liver disease 68 Solesta TM 68 Lowers Risk 68 candesartan cilexetil 68 overactive bladder syndrome 68 aripiprazole Abilify 68 induce orthostatic hypotension 68 Hepatotoxicity 68 chronic idiopathic thrombocytopenic purpura 68 included neutropenia anemia 68 Peginterferon 68 SUPPRELIN R LA 68 post herpetic 68 Gene Mutation Linked 68 TNF Tumor Necrosis Factor 68 Improves Survival 68 Prednisone Against Refractory 68 Cutaneous T 68 Postmenopausal 68 idiopathic thrombocytopenic purpura ITP 68 oropharyngeal candidiasis OPC 68 Fondaparinux 68 SNT-MC#/idebenone 68 psoriatic arthritis PsA 68 BARACLUDE ® 68 acute mania 68 Knee Osteoarthritis 68 Monopril 68 Randomized Phase 68 Initiates Enrollment 68 Ribavirin causes 68 receiving PEGINTRON 68 Parnate 68 Elderly Patients 68 treat benign prostatic 68 Chronic Lung 68 Bone Metastases 67 Pivotal Phase III 67 hoFH 67 C1 INH deficiency 67 interferon gamma 1b 67 Initiates Phase III 67 J Am Coll 67 risperidone Risperdal 67 phenytoin Dilantin 67 achieved CCyR 67 ZOLINZA 67 Inflammatory Markers 67 humanized interleukin 6 67 moderate renal impairment 67 Safinamide 67 INTEGRILIN R 67 Glatiramer Acetate 67 Teva Provides Update 67 Hormone Receptor Positive 67 Teriparatide 67 Nesiritide 67 reduce serum phosphate 67 Effectively Treats 67 Improve Survival 67 Syncria R 67 Tolvaptan 67 subependymal giant cell 67 Premenopausal Women 67 ribavirin USP 67 develop HBV reactivation 67 Bucindolol 67 Acute Decompensated Heart Failure 67 Ziprasidone 67 Levels Linked 67 Generalized Anxiety Disorder 67 Soft Tissue Sarcoma 67 zoledronic acid Reclast 67 Pulmonary Arterial Hypertension 67 thalidomide Thalomid 67 Phase IIb Trial 67 Initiate Clinical Trial 67 receiving INTRON 67 receiving TNF blockers 67 Treatment Shows Promise 67 AFREZZA TM 67 Silodosin 67 thetreatment 67 NICE Recommends 67 Paliperidone Palmitate 67 antiretroviral naïve 67 Rheumatoid Arthritis Patients 67 Diabetic Neuropathy 67 GH deficiency 67 Vidaza ® 67 Irritable Bowel 67 Decitabine 67 Diabetic Nephropathy 67 Increased Mortality 67 FDA Okays 67 Prospective Randomized 67 GOUT 67 Is Well Tolerated 67 receiving immunosuppressive therapy 67 Phase 2b Study 67 oxycodone CR 67 CYT# potent vascular disrupting 67 headache abdominal pain 67 Allogeneic 67 imipramine Tofranil 67 selective modulator 67 LYSTEDA 67 Acute Renal Failure 67 Chemoradiation 67 Genes Predict 67 Long Term Efficacy 67 Cervical Dystonia 67 abacavir Ziagen 67 discontinued Viread 67 Dasatinib 67 Overactive Bladder 67 Inhaled nitric oxide 67 Ovarian Cancer Patients 67 weekly subcutaneous injections 67 FUSILEV enhances 67 Coronary Artery Bypass Graft 67 BCG refractory carcinoma 67 PRN FDA Approves 67 Chronic Hepatitis C 67 Certolizumab pegol 67 Intravitreal 67 receiving VELCADE 67 Romidepsin 67 See WARNINGS 67 Chronic Bronchitis 67 Often Misdiagnosed 67 Shows Promise Against 67 Hospital Acquired Pneumonia 67 Hemodialysis Patients 67 severe hepatic insufficiency 67 opioid naive 67 Myelodysplastic Syndrome 67 invasive candidiasis 67 kidney urologic 67 chronic rheumatic 67 HER2 Positive 67 Non Alcoholic Fatty 67 HER2 Positive Breast Cancer 67 Proves Effective 67 somatostatin analog 67 haloperidol Haldol 67 Randomized Double blind 67 IMiDs ® 67 Diabetic Foot Ulcer 67 chronic granulomatous disease 67 Phase 2b Trial 67 FOLFOX6 chemotherapy regimen 67 Reminyl galantamine 67 nephropathic cystinosis cystinosis 67 biliary tract cancer 67 Begins Dosing 67 Intracerebral 67 insulin glulisine 67 Chronic Hepatitis B 67 Treatment Experienced 67 Previously Untreated 67 Progressive Multifocal Leukoencephalopathy 67 Temsirolimus 67 Carotid Stenting 67 hormone refractory metastatic prostate 67 hypokalemia hypomagnesemia 67 ATACAND 67 acetonide FA 67 either acutely decompensated 67 Treating Chronic 67 hyperlipidemia hypertension 67 pregabalin Lyrica 67 demonstrated antitumor activity 67 unresectable tumors 67 Castration Resistant Prostate Cancer 67 Ischemic 67 Carbamazepine 67 Mouse Model 67 Known hypersensitivity 67 treatment naive genotype 67 Shows Efficacy 66 pravastatin Pravachol 66 Acute Myocardial Infarction 66 Initiate Phase 66 Navelbine ® 66 Vidaza azacitidine 66 Cancer Incidence Mortality 66 R abatacept 66 unresectable recurrent 66 MDS MPD 66 NPH insulin 66 Intervention Effectiveness 66 PROCRIT ® 66 convulsive disorders 66 Ropinirole 66 Chronic Renal Failure 66 Aliskiren 66 Hyperkalemia 66 Poorly Controlled 66 complement inhibitor eculizumab 66 ziprasidone Geodon 66 NOLVADEX 66 Hypertensive Patients 66 Teriflunomide 66 sorafenib Nexavar 66 Preclinical Study 66 Benign Prostatic Hyperplasia 66 paroxetine sertraline 66 abacavir lamivudine 66 alpha1 antitrypsin deficiency 66 Respiratory Distress 66 naïve HCV 66 Helicobacter pylori eradication 66 Newly Diagnosed Patients 66 Pegylated Interferon 66 Romiplostim 66 Endometrial Cancer 66 Therapy Improves 66 Gene Linked 66 macular edema secondary 66 CYP#A# substrate 66 evaluating tivozanib 66 autoantibody positive 66 Hydralazine 66 Dapagliflozin 66 Atorvastatin Evaluation 66 Platinol ® 66 Levoleucovorin 66 Treatment Reduces 66 Demonstrates Efficacy 66 fluvastatin 66 methylnaltrexone bromide 66 Peginterferon alfa 2b 66 Fluconazole 66 polycythemia vera essential thrombocythemia 66 interferon alpha IFN 66 Infected Patients 66 mitoxantrone plus 66 Single Dose 66 Adenomas 66 INCB# [003] 66 Tigecycline 66 NATRECOR ® 66 Zarnestra 66 Showed Significant 66 Lupus Nephritis 66 AVN# Phase 66 rheumatoid arthritis osteoarthritis ankylosing 66 primary dysmenorrhea 66 NAVISTAR R 66 Kit CD# positive 66 Cholesterol Lowering Drug 66 Follicular Lymphoma 66 LENALIDOMIDE 66 Recurrent Breast Cancer 66 Paraplatin ® 66 Serious Infections 66 Danazol 66 juvenile myoclonic epilepsy 66 glucocorticoid induced osteoporosis 66 II Clinical Trial 66 Nitazoxanide 66 Adenoma 66 Hypoactive Sexual Desire Disorder 66 Bone Fracture 66 idiopathic thrombocytopenic purpura 66 Breast Cancer Recurrence 66 treatment naïve genotype 66 undergoing elective percutaneous 66 sorafenib tablets 66 sitaxsentan 66 Sleep Disturbances 66 Neovascular Age Related Macular 66 Pharmacokinetics PK 66 constipation OIC 66 T1DM 66 Launches Generic Version 66 noninvasive outpatient 66 cause cardiac channelopathies 66 Sustained Efficacy 66 leukopenia pancytopenia thrombocytopenia 66 Clinical Trial Evaluating 66 Valvular Heart Disease 66 Epilepsy Drug 66 papillary renal cell carcinoma 66 nicardipine 66 catheter occlusion 66 Obesity Linked 66 Infusion Reactions Severe 66 secondary amenorrhea 66 Eszopiclone 66 Initiates Clinical Trial 66 Treated Patients 66 Toremifene 66 Invasive Breast Cancer 66 Idiopathic Pulmonary Fibrosis 66 acyclovir Lauriad R 66 CTAP# Capsules 66 serotonin norepinephrine reuptake inhibitor 66 Nonalcoholic Steatohepatitis 66 Suicidality 66 Double Blind Placebo 66 Randomized Phase II 66 venlafaxine XR 66 Carotid Revascularization Endarterectomy vs. 66 Survival Benefit 66 Treatment Naïve 66 HMG CoA reductase inhibitors 66 First Patient Enrolled 66 Intracerebral Hemorrhage 66 symptomatic hyponatremia 66 treats paroxysmal nocturnal 66 Randomized Double Blind 66 azilsartan medoxomil 66 CLARITY TIMI 66 Diabetic Macular Edema 66 Intravenous immunoglobulin 66 8mg/kg 66 metastatic GIST 66 Zoloft sertraline 66 HIV treatments Reyataz 66 colesevelam HCl 66 FDA Approves Generic 66 Phase 2a Clinical Trial 66 paclitaxel Taxol R 66 evaluating Actimmune 66 hepatorenal syndrome 66 dermatologic reactions 66 hypercholesterolemic patients 66 Liprotamase 66 Latuda 66 phase III isavuconazole 66 CYP#A# CYP#D# 66 Parathyroid Hormone 66 epoetin alpha 66 Chronic Myelogenous Leukemia 66 FDA Approvals 66 null responder 66 daily subcutaneous injections 66 PEGylated Fab fragment 66 containing abacavir 66 LAB CGRP 66 Successfully Treated 66 Vitrasert R 66 fistulizing Crohn disease 66 paroxetine Paxil 66 Severe Asthma 66 Nat Rev 66 allogeneic HSCT 66 Pulmonary Arterial Hypertension PAH 66 Viagra Soft Cialis Soft 66 Valvular 66 heparin induced thrombocytopenia 66 Multidrug 66 onabotulinumtoxinA 66 Patients Suffering 66 stage IIIb IV 66 tolterodine ER 66 Aggressive Reduction 66 Breast Cancer Treatment 66 Familial Hypercholesterolemia 66 systemic juvenile idiopathic 66 Callisto initiated 66 Refractory Angina 66 hypertrichosis occurred 66 Atopic Dermatitis 66 metastatic castration resistant 66 Fingolimod 66 Cariprazine 66 ulcerative colitis Crohn disease 66 benign prostatic hypertrophy BPH 66 Treatment Resistant 66 See CONTRAINDICATIONS 66 paricalcitol 66 DEB# 66 Mellaril 66 Well Tolerated 66 Chronic Sinusitis 66 elevated transaminases 66 smoldering multiple myeloma 66 Cognitive Deficits 66 Plavix clopidogrel bisulfate 65 visilizumab 65 GW# [003] 65 Eculizumab 65 pioglitazone hydrochloride 65 Montelukast 65 gefitinib Iressa 65 relapsing multiple sclerosis 65 Initiates Phase II 65 Myelofibrosis 65 rosuvastatin Crestor 65 invasive aspergillosis 65 nondiabetic patients 65 Left Ventricular Hypertrophy 65 ORENCIA R 65 undergoing peritoneal dialysis 65 Kidney Transplant Patients 65 Cardiac Resynchronization 65 novel VDA molecule 65 Myelodysplastic Syndromes 65 Hypotension 65 Denufosol 65 Desvenlafaxine 65 Hyperphosphatemia 65 Predict Response 65 malignant ascites 65 Actonel risedronate 65 Hydrochlorothiazide Tablets 65 sunitinib Sutent 65 Investigational Oral 65 metastatic gastric 65 Rheumatoid Arthritis RA 65 JAK2 Inhibitor 65 Selective serotonin reuptake inhibitors 65 anagrelide 65 Testosterone Therapy 65 humanized therapeutic 65 Lung Cancer Patients 65 diabetic gastroparesis 65 tenofovir emtricitabine 65 oxypurinol 65 Thromboembolic 65 R metformin Concor 65 desvenlafaxine succinate 65 Phenylketonuria 65 Picoplatin Efficacy After 65 IN PATIENTS WITH 65 Acute Ischemic Stroke 65 minimally symptomatic 65 registrational Phase 65 Systemic Sclerosis 65 pentostatin 65 Clostridium difficile Infection 65 Treating Heart Failure 65 Peptide YY 65 Bayer HealthCare Onyx Pharmaceuticals 65 pulmonary hypertension PH 65 Hepatocellular Carcinoma 65 known sulfonamide allergy 65 nucleotide analogue 65 approved incretin mimetic 65 toenail onychomycosis 65 familial hypercholesterolemia 65 mild hepatic impairment 65 angioneurotic edema 65 Known generically 65 Preclinical Models 65 Mycophenolate Mofetil 65 Papillary 65 inhalation powder 65 neutropenic sepsis 65 AVASTIN 65 REYATAZ ® 65 lamotrigine Lamictal 65 Beta Blocker 65 Gastric Cancer 65 CIMZIA R 65 Kidney Failure 65 desire disorder HSDD 65 Vildagliptin 65 Bucindolol Based 65 Study Shows Promise 65 TOPAMAX R 65 Eprodisate 65 Prospective Multicenter 65 Treatment Naive HIV 65 orally inhaled migraine 65 Novel Oral 65 reflux disease GERD 65 Phase III Pivotal 65 idiopathic PAH 65 rufinamide 65 endometrial hyperplasia 65 Amgen Neulasta ® 65 Female Stress Urinary 65 aldosterone antagonists 65 Pivotal Clinical Trial 65 Anthracycline 65 Schizophrenia Treatment 65 rasagiline tablets 65 Folfox 65 Lymphocytic 65 Advanced Colorectal Cancer 65 MGd 65 Phase IIa Clinical Trial 65 paclitaxel cisplatin 65 Sodium oxybate 65 Fludarabine 65 buccal tablets 65 #:#-#,# CrossRef Medline [002] 65 Paliperidone ER 65 oral ghrelin agonist 65 Adjuvant chemotherapy 65 Zeldox 65 Juvenile Idiopathic Arthritis JIA 65 Community Acquired Pneumonia 65 refractory gout 65 humanised monoclonal antibody 65 chronic myeloid 65 Testosterone MDTS R 65 Antipsychotic Medications 65 Postmenopausal Women 65 Drug Combo 65 Avandia Actos 65 Risperdal risperidone 65 citalopram Celexa 65 Arch Neurol 65 Natalizumab 65 non resectable metastatic 65 IMiDs ® compound 65 PROSTVAC VF 65 Acute Myeloid Leukaemia AML 65 efalizumab 65 N Engl J 65 Pegylated Liposomal Doxorubicin 65 Demonstrate Significant 65 Physician Insights 65 number NCT# ClinicalTrials.gov 65 Lung Injury 65 Critically Ill Patients 65 Abilify aripiprazole 65 vaginal candidiasis 65 Advanced Prostate Cancer 65 reuptake inhibitor 65 Chronic HCV 65 relapsing remitting MS RRMS 65 vapreotide acetate 65 Omacetaxine 65 Drug Shows Promise 65 CHARM Added 65 gastrointestinal stromal tumors GIST 65 recurrent malignant glioma 65 atypical hemolytic uremic syndrome 65 Angioedema 65 Elitek 65 amalgam fillings mercury vapor 65 steroid refractory ulcerative 65 ExTRACT TIMI 65 Alequel 65 Advanced Renal Cell 65 Skeletal Muscle 65 lymphomas leukemias 65 Severe Primary IGFD 65 induced macular edema 65 EXJADE 65 symptomatic BPH 65 post herpetic neuralgia PHN 65 unstable angina UA 65 chronic lymphocytic 65 Myocardial Infarction Study 65 Cardiovascular Outcomes 65 haematologic 65 Cholesterol Levels SPARCL 65 Enlarged Prostate 65 Lung Cancer Survival 65 Janssen Risperdal 65 Bronchodilator 65 Catapres 65 plus dexamethasone 65 Prostate Cancer Patients 65 Gonal f R 65 Meta Analysis 65 Inhaled Corticosteroids 65 Muraglitazar 65 fluvastatin Lescol 65 MetroGel 65 pancreatic insufficiency 65 HCV RESPOND 2 65 Arch Intern Med 65 chemoradiation therapy 65 cytomegalovirus infection 65 TO AVOID PREGNANCY WHILE 65 Randomized Study 65 Pamidronate 65 Vasomotor Symptoms 65 Femara letrozole 65 Delayed Release 65 Peripheral Arterial 65 Posaconazole 65 Percutaneous vertebroplasty 65 Tipranavir 65 Atherosclerotic 65 Etanercept 65 Flu Cy 65 antidepressants fluoxetine 65 Acute Heart Failure 65 Commonly prescribed 65 Azathioprine 65 Belimumab 65 R sorafenib tablets 65 COPEGUS R 65 Initiates Dosing 65 lipohypertrophy 65 Insulin Sensitivity 65 cromolyn sodium 65 Hsp# Inhibitor 65 OMP #R# 65 Luvox fluvoxamine 65 recurrent glioma 65 Genentech Rituxan 65 refractory cutaneous T 65 dyskeratosis congenita 65 Controlled Study 65 Tumor Response 65 Ramelteon 65 5 Fluorouracil 65 debilitating complication 65 Val HeFT 65 Subgroup analysis 65 Pramlintide 65 Basal Cell 65 IV Busulfex 65 Phenylketonuria PKU 65 Overactive Bladder OAB 65 Roche Boniva 65 lipid elevations 65 Autoantibodies 65 Interferon beta 1b 65 recurrent metastatic 65 LymphoStat B belimumab 65 Non Invasive Treatment 65 Doxil ® 65 pseudobulbar affect PBA 65 Daclizumab 65 Vaccine Protects Against 65 clomipramine 65 Improved Survival 65 Disease Progression 65 efaproxiral 65 apomorphine hydrochloride 65 chronic renal disease 65 Bronchiectasis 65 acute porphyria 65 heFH 65 SEROQUEL R 65 vinorelbine tartrate 65 Chronic Lymphocytic Leukemia 65 Edge STudy 65 Disease Modifying 65 FIRMAGON 65 Cimzia TM 65 rheumatoid arthritis inflammatory bowel 65 Multiple Ascending Dose 65 Double Blind Randomized 65 Completes Enrollment 65 Fabry Disease 65 comparator arm 65 denileukin diftitox 65 Myeloma Patients 65 Initiated Phase 65 PROCRIT R 65 Glucocorticoid 65 memantine HCl 65 Crit Rev 65 somnolence dizziness 64 Vaginal Gel 64 Irinotecan 64 administered cetrorelix 64 Short Stature 64 docetaxel Taxotere ® 64 Phase Ib IIa 64 severe renal impairment 64 Advanced Solid Tumors 64 smoldering myeloma 64 Plaquenil 64 Efficacy Trial 64 LymphoStat B TM 64 RLAI 64 immune thrombocytopenic purpura 64 Chemotherapy induced 64 #mg/day [002] 64 chronic hemodialysis 64 Azacitidine 64 Antipsychotic 64 Raptiva ® 64 Acute Myelogenous Leukemia 64 brand ciclesonide HFA 64 Androgen Deprivation Therapy 64 flecainide 64 indinavir Crixivan 64 metformin XR 64 Carcinoid 64 Advanced Ovarian Cancer 64 Accelerated Partial Breast Irradiation 64 Clinical Trial Results 64 Exacerbation 64 adefovir dipivoxil 64 Antiangiogenic 64 neovascular form 64 Blind Placebo Controlled Trial 64 Phase 2a Trial 64 systemic hypotension 64 esophageal candidiasis 64 Treat Parkinson Disease 64 oral rivaroxaban 64 BUPHENYL ® sodium phenylbutyrate 64 Surgical Treatment 64 resistant hormone refractory 64 administering XIFAXAN 64 Stage IIB 64 Desvenlafaxine Succinate 64 tumors GIST 64 patients coinfected 64 Orthostatic Hypotension 64 Ranolazine 64 SIADH 64 Bosentan 64 sitagliptin metformin 64 % Caprylate Chromatography 64 Acute Coronary Syndromes ACS 64 Pioglitazone 64 Combo Therapy 64 underwent resection 64 VIIBRYD 64 Minimally Invasive Procedure 64 Solid Tumors 64 gastrointestinal stromal tumor GIST 64 dasatinib Sprycel ® 64 galiximab 64 novel orally inhaled 64 Venous Thromboembolism 64 Polyneuropathy 64 Anti VEGF 64 Inhalation Aerosol 64 nortriptyline Pamelor 64 Symptom Relief 64 Personalized Immunotherapy 64 pan histone deacetylase 64 rhIGF-I/rhIGFBP-3 64 Drug Candidate 64 acute myeloid 64 riociguat 64 Phase Ib Clinical Trial 64 unfractionated heparin UFH 64 Kinoid 64 J Clin 64 resectable pancreatic cancer 64 Renal Artery 64 Immunotherapeutic 64 morphometric vertebral fractures 64 Fungal Infections 64 plus COPEGUS 64 cardiovascular calcification 64 TLK# 64 PEG IFN 64 5 FU leucovorin 64 Lubiprostone 64 Services #:#-#,# Abstract 64 JAK Inhibitor 64 fructose intolerance 64 cetuximab Erbitux R 64 #:#-#,# CrossRef Medline [001] 64 Clinical Efficacy 64 plus prednisone 64 Paclitaxel Carboplatin 64 Hypertrophy 64 perioperatively 64 Fulvestrant 64 Interferon Beta 64 Eur J 64 metformin sulfonylurea 64 Prognostic Factors 64 ANN INTERN MED 64 topiramate Topamax 64 Topamax topiramate 64 Transplant Rejection 64 BRIM2 64 K ras mutations 64 ritonavir boosted 64 phosphodiesterase inhibitor 64 Sanofi Pasteur Fluzone 64 neurogenic bladder 64 transthyretin amyloidosis 64 ß blockers 64 Oral Formulation 64 NDA Submission 64 Demonstrates Significant 64 erythematosus 64 dasatinib Sprycel 64 Carbidopa Levodopa 64 gastro oesophageal reflux 64 cystic fibrosis chronic pancreatitis 64 arthritis PsA 64 Cell Lymphoma CTCL 64 MEK Inhibitor 64 Therapeutic Efficacy 64 Alteplase 64 Growth Hormone Deficiency 64 Initiates Phase 2b 64 basiliximab 64 pretransplant 64 Pivotal Study 64 generalized edema 64 headache nasopharyngitis 64 Antigen Specific 64 Statin Drugs 64 Phase III ADT 64 R entecavir 64 #mg #mg #mg [003] 64 Phase III Clinical Trial 64 lichen planus 64 myeloid metaplasia 64 Levetiracetam 64 Randomized Controlled Trials 64 Moxifloxacin 64 Cancer Patients Treated 64 Rare Genetic 64 Lexapro Effexor Serzone 64 STRIDE PD 64 Mitomycin C 64 intravesical infusion therapy 64 ALN HPN 64 Seroquel quetiapine 64 CLINICAL STUDIES 64 J Nutr 64 Prilosec omeprazole 64 invasive lobular carcinoma